A A A

F F F

C C C

Introduction Alphabetic List Types of Intervention

Assistive and Adaptive Technology Augmentative and Alternative Communication Behavioural and Developmental Biomedical Interventions Complementary and Alternative Medicine Diets and Supplements Educational Interventions Medical Procedures Medications

Central Nervous System Medications Cardiovascular and Respiratory Medications Endocrine System Medications Immunology and Infection Medications Antipsychotics

Aripiprazole Haloperidol Olanzapine Risperidone Other Antipsychotics

Motor Sensory Interventions Parent Training and Support Psychological Interventions Social Care Standard Health Care Vocational Interventions Other Interventions

Our Evaluations Harmful Interventions Making the Decision Other Aspects

Haloperidol and Autism

Haloperidol is a type of conventional or typical antipsychotic drug, which is sold under various brand names including Haldol, Haldol Concentrate and Haloperidol Intensol.

It is used to treat psychotic disorders and symptoms such as hallucinations, delusions, and hostility and to control muscular tics of the face, neck, hands, and shoulders.

It is also used to treat severe behavioural problems in some individuals on the autism spectrum.

Related Glossaries

Haloperidol

Related Publications

Anderson L. T. et al. (1984) Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms American Journal of Psychiatry. 141(10), Read Abstract (New Window)
Anderson L. T. et al. (1989) The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Developmental Disorders. 19(2), Read Abstract (New Window)
Campbell M. et al. (1978) A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child and Adolescent Psychiatry. 17(4), Read Abstract (New Window)
Campbell M. et al. (1982) The effects of haloperidol on learning and behavior in autistic children. Journal of Autism and Developmental Disorders. 12(2), Read Abstract (New Window)
Gencer O. et al. (2008) Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study. European Child and Adolescent Psychiatry. 17(4), Read Abstract (New Window)
Malone R. P. et al. (2001) Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. Journal of the American Academy of Child and Adolescent Psychiatry. 40 Read Abstract (New Window)
Perry R. et al. (1989) Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. Journal of the American Academy of Child and Adolescent Psychiatry. 28 Read Abstract (New Window)
Remington G. et al. (2001) Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. Journal of Clinical Psychopharmacology. 21(4), Read Abstract (New Window)
Serrano. A. (1981) Haloperidol: its use in children. Journal of Clinical Psychiatry. 42(4), Read Abstract (New Window)
Silva R. R. et al. (1993) Haloperidol withdrawal and weight changes in autistic children. Psychopharmacology Bulletin. 29(2), Read Abstract (New Window)

Quick link:: https://www.informationautism.org/haloperidol

Updated: 18 Jun 2018

Rate This Page

Poor | Satisfactory | Good | Excellent

Print This Page / view All

Information Autism service, part of the John and Lorna Wing Foundation.

Registered as a charity in England and Wales (1156443). © The John and Lorna Wing Foundation 2021.